Cargando…
Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D
Multi drug resistance (MDR) is a serious obstacle in the management of breast cancer. Therefore, overcoming MDR using novel anticancer agents is a top priority for medicinal chemists. It was found that dihydropyridines lacking calcium antagonistic activity (e.g acridinediones) possess MDR modifier p...
Autores principales: | Moallem, S.A., Dehghani, N., Mehri, S., Shahsavand, Sh., Alibolandi, M., Hadizadeh, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621628/ https://www.ncbi.nlm.nih.gov/pubmed/26600848 |
Ejemplares similares
-
Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones asPotassium Channel Openers in Isolated Rat Aorta
por: Imenshahidi, Mohsen, et al.
Publicado: (2012) -
Virtual Screening for Finding Novel COX-2 Inhibitors as Antitumor
Agents
por: Badieyan, Zohreh S, et al.
Publicado: (2012) -
Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer
por: Perez White, Bethany, et al.
Publicado: (2013) -
Sex chromosome aneuploidies and fertility: 47,XXY, 47,XYY, 47,XXX and 45,X/47,XXX
por: Rogol, Alan D
Publicado: (2023) -
Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells
por: Men, Xin, et al.
Publicado: (2021)